Single agent 48 hour treatment of IFN-α resulted in a minimal increase in apoptotic cell death in both BRAF V600E mutant (A375) and BRAF wild-type (WM1366) human melanoma tumor cells (4.9 ± 1.8 % and 12.5 ± 0.8%, respectively). This evidence concerns the gene IFNA2 and melanoma.